Plunkett Research Online: Eleven Biotherapeutics Inc

ELEVEN BIOTHERAPEUTICS INC (EBIO:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Eleven Biotherapeutics Inc operates in the healthcare sector in the United States. The Company applies its AMP-Rx platform to the discovery and development of protein therapeutics to treat diseases of the eye. Its major product candidate is the EBI-031, which was designed, engineered and generated u.....



Eleven Biotherapeutics Inc
Ticker: EBIO
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 617 871-9911
Fax: 617 858-0911
Address: 215 First Street
Suite 1800
Cambridge, MA 02142 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing
ContactsDescription
Richard FitzgeraldCFO/Secretary/Treasurer
Wendy DixonChairman of the Board/Director
See More
Eleven Biotherapeutics Inc operates in the healthcare sector in the United States. The Company applies its AMP-Rx platform to the discovery and development of protein therapeutics to treat diseases of the eye. Its major product candidate is the EBI-031, which was designed, engineered and generated u.....See More See More

Auditor: Ernst & Young LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201620152014201320122011
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: